Exclusive

Publication

Byline

Ozempic an "epic launch" in India: Novo Nordisk India MD Vikrant Shrotriya

MUMBAI, Dec. 12 -- Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, pricing the entry 0.25 mg dose at Rs.8,800 for a four-week course. The launch comes ... Read More


With a Rs.2,200-a-week price tag, Ozempic enters India as Novo Nordisk steps up its obesity bet

MUMBAI, Dec. 12 -- Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, with a headline starting price of Rs.2,200 per week. For a four-week course, the ent... Read More


French drugmaker Servier firms up India focus with manufacturing tie-ups, trial plans

New Delhi, Dec. 10 -- French pharmaceutical group Servier is sharpening its India strategy with a string of new oncology launches focused on rare cancers, plans for local manufacturing of active ingre... Read More


Biocon to merge biologics unit in $5.5 billion deal

New Delhi, Dec. 6 -- Biocon Ltd will integrate Biocon Biologics Ltd as a wholly owned subsidiary in a deal valuing the unit at $5.5 billion, the company said on Saturday. Biocon will acquire the rema... Read More


Mint Explainer: Does India need special courts for complex drug patent wars?

Mumbai, Dec. 6 -- On 2 December, the Delhi high court allowed domestic drugmaker Dr Reddy's Laboratories Ltd to manufacture the blockbuster weight-loss injection semaglutide, for which global pharma g... Read More


General Atlantic-backed ASG Eye Hospital eyes Rs.2,000 crore investment for expansion by 2030

New Delhi, Dec. 4 -- General Atlantic and Kedaara Capital-backed eyecare chain ASG Eye Hospital plans to invest Rs.1,500-2,000 crore by 2030 to expand its footprint in small cities, signalling growing... Read More


APIs to innovation: Bulk drug cos ramp up CDMO bets

MUMBAI, Dec. 1 -- Once focused on low-margin active pharmaceutical ingredients (APIs), India's bulk drug manufacturers are raising their ambitions, with several now investing heavily in R&D to win con... Read More


From APIs to innovation: India's bulk drug makers ramp up CDMO bets

MUMBAI, Nov. 29 -- Once focused on low-margin active pharmaceutical ingredients (APIs), India's bulk drug manufacturers are stepping up their ambitions. Several are now pouring capital into research a... Read More


Mint Explainer: Delhi air pollution crisis: Does India have a health adaptation plan?

Mumbai, Nov. 20 -- India's national capital has seen two citizen-led protests in November over the government's inaction to address dangerously worsening air quality. Health experts have declared the... Read More


Qure.ai to scale up govt partnerships for health screenings in India

New Delhi, Nov. 18 -- Healthcare startup Qure.ai is betting on partnerships with central and state governments as it seeks to scale its artificial intelligence-led diagnostic tools, particularly for d... Read More